Arrowhead Conferences' 2nd Annual Drug Delivery Summit to Take Place May 1st-2nd, 2008 in San Francisco

Share Article

Arrowhead Publishers and Conferences is proud to announce that it is hosting its 2nd Annual Drug Delivery Summit: New Technologies and Commercialization Trends in San Francisco, California on May 1st and 2nd, 2008.

News Image

Arrowhead Publishers and Conferences is proud to announce that it is hosting its 2nd Annual Drug Delivery Summit: New Technologies and Commercialization Trends in San Francisco, California on May 1st and 2nd, 2008.

Background and Focus:
As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors. The drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products. Drug delivery companies not only stand to benefit from patent expiry by providing their reformulation services to pharmaceutical companies, but also by producing their own versions of branded products with improved delivery mechanisms.The current value of the drug delivery market has been estimated at over USD$65 billion.

Arrowhead's 2nd Annual Drug Delivery Summit will provide a forum for leaders from both the drug delivery and pharmaceutical industry to discuss the challenges and opportunities facing the development of new drug delivery technologies and therapies utilizing cutting-edge drug delivery technologies. This conference will not only assess new drug delivery systems and technologies, but will provide instruction and case studies on successful licensing and deal-making in this sector.

With sessions covering both the technical and business sides of the industry, this conference has been organized with both the scientist and business professional in mind.

Key themes of this conference will include:

  •     An examination of key emerging technologies in the following areas:
  • injectable
  • ultrasonic
  • electroporation
  • inhalable
  • transdermal
  • transmucosal
  • nanotechnology
  • controlled release
  • RNAi delivery
  • and other modes of drug delivery
  •     Keys to the formation of successful alliances
  •     Unlocking the door to delivery of macromolecules
  •     Mapping of bioavailability as a key to successful formulation
  •     Overcoming first pass metabolism and absorption window problems
  •     Patent and IP protection in drug delivery
  •     Considerations and best practices in contract manufacturer-drug delivery partnerships
  •     Trends in tumor and organ targeting
  •     Making the deal - structuring mutually beneficial licensing arrangements

Speakers at this event include:

Philip G. Green, Ph.D., Director Alternative Delivery Systems, BD-Medical Pharmaceutical Systems

Yael Weiss, MD, Ph.D, Director Licensing and External Research, Merck & Co.

Tatyana Naranda, Director Business Development, Alexza Pharmaceuticals

Dr. Ron Forster, Director Drug Product & Device Development, Amgen

Philip G. Green, Ph.D., Director Alternative Delivery Systems, BD-Medical Pharmaceutical Systems

Yael Weiss, MD, Ph.D, Director Licensing and External Research, Merck & Co.

Allen Downs, Sr Executive Director Licensing & Business Development, Purdue Pharmaceuticals

Dr. Claire Evans, Director Protein Therapeutics, Ichor Medical Systems

Mark Matthews, VP Commercial Affairs, Javelin Pharmaceuticals

Meghan Fitzgerald, Chief Business Officer, Vion Pharmaceuticals

Dr. Peter Scholes, VP Pharmaceutical Sciences, Pharmaceutical Profiles Ltd.

Ed Cannon, Ph.D, CEO, Aerovectrx

Dr. Verne Cowles, Sr. Director of Preclinical Studies, Depomed

Andrew Forman, Sr Analyst & Managing Director, WR Hambrecht

Judith Kornfeld, Vice President of Business Development, TransPharma Medical

Please visit our website at http://www.arrowheadpublishers.com to view the complete agenda and list of speakers.

Who should attend:

Individuals from the following industries:

  •     Drug delivery companies
  •     Pharmaceutical companies
  •     Biotechnology companies
  •     Specialty pharmaceutical companies
  •     Medical device manufacturers
  •     Investment and capital markets community

Individuals from the following areas/departments will greatly benefit from attending:

  •     Business development
  •     Executive management
  •     Corporate development
  •     Technology assessment
  •     Commercial development
  •     New product planning
  •     Drug delivery scientists
  •     Pharmaceutical science
  •     Licensing
  •     Intellectual property
  •     Outsourcing
  •     Strategic planning & development
  •     Scientific / technology development
  •     Marketing
  •     R&D

as well as individuals from

  •     Investment banks and venture capitalist firms
  •     Academic institutions
  •     Consultancies

For more information about this conference, please visit http://www.arrowheadpublishers.com/conferences/drugdelivery2008/ or contact us at 312-244-3703 or arrowheadconferences @ arrowheadpublishers.com

To enquire about sponsorship and/or exhibiting at this conference please contact marketing @ arrowheadpublishers.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author